Sign inJoin waitlistJoin the waitlist

Julia J Wattacheril

Director of the Metabolic Dysfunction-Associated Liver Disease (MASLD) Program · Columbia University Irving Medical Center

Credentials: · · · · ·

History

Metabolic Dysfunction-Associated Liver Disease (MASLD) Program · Columbia University Irving Medical Center
Present
CUMC
Present

NewYork-Presbyterian Hospital/Columbia University Medical Center
Until 2011
Vanderbilt University Medical Center
Baylor College of Medicine
Baylor College of Medicine
2004

Research

Hepatic TLR4 signaling in obese NAFLD
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2015 · 213 citations
AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review
Review · Gastroenterology · 2023 · First of 4 authors · Corresponding · 182 citations
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis
Systematic review or meta-analysis · Journal of Hepatology · 2021 · 117 citations

Naga Chalasani
9 papers
Andrew Scanga
6 papers
Naji Abumrad
6 papers
Andrew DeLemos
5 papers
Arun Sanyal
5 papers
Meaghan Phipps
5 papers
Samer Gawrieh
5 papers
AG
Averill Guo
4 papers · 4 as a resident
Ethan Miller
4 papers
LD
Lara Dakhoul
4 papers · 4 as a fellow
Sydney Pomenti
4 papers
JL
Joel Lavine
3 papers

Clinical trials

Utilization of MAsS in Patients Undergoing LT for HCC
Principal investigator · Terminated
Columbia University
2022–2023
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Sub-investigator · Not yet recruiting · Phase 1
Columbia University
2027–2029
Effect of Insulin Lowering on Lipogenesis
Sub-investigator · Recruiting · Phase 1
Columbia University
2026–2029
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Sub-investigator · Recruiting · Phase 1
Columbia University
2024–2026